Inventor · disambiguated record
Paul M. Simon
Also filed as: SIMON PAUL M · SIMON PAUL MOORE
9 granted patents·3 pending applications·307 citations·filing 1993–2012
91Inventor score
Top patents by PatentIndex Score
12 records- 0190US8318912B2Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptideSIMON PAUL M·Filed 2007·Granted Nov 27, 2012·29 cites·23 claims
- 0286US5514660AMethod for treating and inhibiting gastric and duodenal ulcersNEOSE PHARM INC·Filed 1995·Granted May 7, 1996·64 cites·18 claims
- 0385US5883079AMethod for inhibiting H. pylori infection in mammalian tissueNEOSE TECHNOLOGIES INC·Filed 1998·Granted Mar 16, 1999·56 cites·7 claims
- 0481US5736533ABacterial inhibition with an oligosaccharide compoundNEOSE TECHNOLOGIES INC·Filed 1995·Granted Apr 7, 1998·51 cites·16 claims
- 0578US6001819ABacterial inhibition with an oligosaccharide compoundNEOSE TECHNOLOGIES INC·Filed 1998·Granted Dec 14, 1999·42 cites·3 claims
- 0677US5753630AMethod for treating and inhibiting gastric and duodenal ulcersNEOSE TECHNOLOGIES INC·Filed 1996·Granted May 19, 1998·36 cites·9 claims
- 0760US5707844AImmunoassay reagents and methods for detecting brequinar and analogsDU PONT MERCK PHARMA·Filed 1995·Granted Jan 13, 1998·7 cites·20 claims
- 0858US6096725AMethods of using αGal oligosaccharides as immune system targeting agentsNEOSE TECHNOLOGIES INC·Filed 1997·Granted Aug 1, 2000·11 cites·8 claims
- 0954US5393891AImmunoassay reagents and methods for detecting brequinar and analogsDU PONT MERCK PHARMA·Filed 1993·Granted Feb 28, 1995·11 cites·4 claims
- 1051US2004228831A1Polymeric conjugates for tissue activated drug deliveryFiled 2003·Application pending·0 cites
- 1145US2013071413A1Targeted immune conjugatesSIMON PAUL M·Filed 2012·Application pending·0 cites
- 1237US2013115230A1Delivery proteinsSIMON PAUL M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul M. Simon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →